Do analysts recommend NVNO or PSTV?

Plus Therapeutics has a consensus price target of $56.40, suggesting a potential upside of 1,372.58%. Given Plus Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Plus Therapeutics is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Plus Therapeutics 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43

Do analysts recommend NVNO or PETV?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is NVNO or PETV more profitable?

enVVeno Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. enVVeno Medical's return on equity of -66.39% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets enVVeno Medical N/A -66.39% -60.42% PetVivo -902.82% -4,813.07% -281.78%

Do analysts rate NVNO or CTSO?

Cytosorbents has a consensus price target of $5.38, suggesting a potential upside of 1,393.06%. Given Cytosorbents' higher probable upside, analysts plainly believe Cytosorbents is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Cytosorbents 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer RVP or NVNO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Do analysts prefer LFWD or NVNO?

Lifeward currently has a consensus target price of $10.00, suggesting a potential upside of 41.84%. Given Lifeward's higher probable upside, equities analysts plainly believe Lifeward is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Is LFWD or NVNO more profitable?

enVVeno Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. enVVeno Medical's return on equity of -66.39% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% enVVeno Medical N/A -66.39% -60.42%

enVVeno Medical (NVNO) Competitors

$10.39 +0.28 (+2.77%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$10.34 -0.04 (-0.43%)

As of 07/24/2026 04:10 PM Eastern

Compare

NVNO vs. PSTV, PETV, CTSO, RVP, and LFWD

Should you buy enVVeno Medical stock or one of its competitors? MarketBeat compares enVVeno Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with enVVeno Medical include Plus Therapeutics (PSTV), PetVivo (PETV), Cytosorbents (CTSO), Retractable Technologies (RVP), and Lifeward (LFWD). These companies are all part of the "medical equipment" industry.

How does enVVeno Medical compare to Plus Therapeutics?

enVVeno Medical (NASDAQ:NVNO) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

enVVeno Medical has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Plus Therapeutics has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

In the previous week, Plus Therapeutics had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for Plus Therapeutics and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.89 beat Plus Therapeutics' score of 1.07 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Overall Sentiment
enVVeno Medical	Very Positive
Plus Therapeutics	Positive

Plus Therapeutics has a consensus price target of $56.40, suggesting a potential upside of 1,372.58%. Given Plus Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Plus Therapeutics is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Plus Therapeutics	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

enVVeno Medical has higher earnings, but lower revenue than Plus Therapeutics. Plus Therapeutics is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A
Plus Therapeutics	$5.21M	5.06	-$22.39M	-$2.30	N/A

34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 15.0% of enVVeno Medical shares are owned by company insiders. Comparatively, 2.5% of Plus Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

enVVeno Medical has a net margin of 0.00% compared to Plus Therapeutics' net margin of -230.24%. enVVeno Medical's return on equity of -66.39% beat Plus Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-66.39%	-60.42%
Plus Therapeutics	-230.24%	-198.48%	-73.13%

Summary

enVVeno Medical beats Plus Therapeutics on 9 of the 16 factors compared between the two stocks.

How does enVVeno Medical compare to PetVivo?

enVVeno Medical (NASDAQ:NVNO) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

enVVeno Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. enVVeno Medical's return on equity of -66.39% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-66.39%	-60.42%
PetVivo	-902.82%	-4,813.07%	-281.78%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

enVVeno Medical has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.23, suggesting that its share price is 23% more volatile than the broader market.

In the previous week, enVVeno Medical and enVVeno Medical both had 1 articles in the media. enVVeno Medical's average media sentiment score of 1.89 beat PetVivo's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Overall Sentiment
enVVeno Medical	Very Positive
PetVivo	Neutral

34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 15.0% of enVVeno Medical shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

PetVivo has higher revenue and earnings than enVVeno Medical. PetVivo is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A
PetVivo	$1.05M	25.88	-$10.95M	-$0.38	N/A

Summary

enVVeno Medical beats PetVivo on 9 of the 13 factors compared between the two stocks.

How does enVVeno Medical compare to Cytosorbents?

enVVeno Medical (NASDAQ:NVNO) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Cytosorbents has higher revenue and earnings than enVVeno Medical. Cytosorbents is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A
Cytosorbents	$37.06M	0.61	-$8.20M	-$0.19	N/A

In the previous week, Cytosorbents had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Cytosorbents and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.89 beat Cytosorbents' score of 0.94 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Overall Sentiment
enVVeno Medical	Very Positive
Cytosorbents	Positive

Cytosorbents has a consensus price target of $5.38, suggesting a potential upside of 1,393.06%. Given Cytosorbents' higher probable upside, analysts plainly believe Cytosorbents is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

enVVeno Medical has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Cytosorbents has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

enVVeno Medical has a net margin of 0.00% compared to Cytosorbents' net margin of -31.85%. enVVeno Medical's return on equity of -66.39% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-66.39%	-60.42%
Cytosorbents	-31.85%	-235.57%	-37.88%

34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by company insiders. Comparatively, 7.8% of Cytosorbents shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

enVVeno Medical and Cytosorbents tied by winning 8 of the 16 factors compared between the two stocks.

How does enVVeno Medical compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Retractable Technologies has higher revenue and earnings than enVVeno Medical. Retractable Technologies is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.55	-$7.01M	-$0.21	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A

In the previous week, enVVeno Medical had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for enVVeno Medical and 0 mentions for Retractable Technologies. enVVeno Medical's average media sentiment score of 1.89 beat Retractable Technologies' score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
enVVeno Medical	Very Positive

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Retractable Technologies has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

enVVeno Medical has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat enVVeno Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
enVVeno Medical	N/A	-66.39%	-60.42%

Summary

Retractable Technologies and enVVeno Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does enVVeno Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

enVVeno Medical has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. enVVeno Medical's return on equity of -66.39% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
enVVeno Medical	N/A	-66.39%	-60.42%

26.8% of Lifeward shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

enVVeno Medical has lower revenue, but higher earnings than Lifeward. enVVeno Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.90	-$19.91M	-$19.66	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A

In the previous week, Lifeward had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Lifeward and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.89 beat Lifeward's score of 0.94 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Positive
enVVeno Medical	Very Positive

Lifeward currently has a consensus target price of $10.00, suggesting a potential upside of 41.84%. Given Lifeward's higher probable upside, equities analysts plainly believe Lifeward is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Lifeward has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market.

Summary

enVVeno Medical beats Lifeward on 10 of the 16 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVNO vs. The Competition

Export

Metric	enVVeno Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.94M	$7.45B	$6.93B	$12.20B
Dividend Yield	N/A	1.33%	2.67%	9.41%
P/E Ratio	-0.41	48.63	27.14	23.62
Price / Sales	N/A	85.01	523.81	89.60
Price / Cash	N/A	25.70	49.81	58.78
Price / Book	0.25	6.73	10.28	6.01
Net Income	-$19.47M	$162.27M	$3.60B	$331.99M
7 Day Performance	-3.80%	-5.05%	-1.27%	-0.63%
1 Month Performance	-5.97%	-5.86%	-0.37%	-2.00%
1 Year Performance	-94.01%	-2.88%	18.30%	13.62%

enVVeno Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVNO enVVeno Medical	1.6958 of 5 stars	$10.39 +2.8%	N/A	-94.1%	$6.94M	N/A	N/A	30	Upcoming Earnings
PSTV Plus Therapeutics	2.6368 of 5 stars	$3.82 -2.6%	$56.40 +1,376.4%	-74.3%	$26.99M	$5.21M	N/A	20
PETV PetVivo	N/A	$0.69 -10.1%	N/A	-10.0%	$26.04M	$1.05M	N/A	20	Gap Up High Trading Volume
CTSO Cytosorbents	2.4804 of 5 stars	$0.38 -3.0%	$5.38 +1,307.4%	-64.0%	$24.74M	$37.06M	N/A	220	Gap Up
RVP Retractable Technologies	N/A	$0.68 +0.3%	N/A	-3.6%	$20.42M	$37.15M	N/A	240

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NVNO) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enVVeno Medical (NVNO) Competitors

NVNO vs. PSTV, PETV, CTSO, RVP, and LFWD

How does enVVeno Medical compare to Plus Therapeutics?

Summary

How does enVVeno Medical compare to PetVivo?

Summary

How does enVVeno Medical compare to Cytosorbents?

Summary

How does enVVeno Medical compare to Retractable Technologies?

Summary

How does enVVeno Medical compare to Lifeward?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

enVVeno Medical (NVNO) Competitors

NVNO vs. PSTV, PETV, CTSO, RVP, and LFWD

How does enVVeno Medical compare to Plus Therapeutics?

Which has more volatility and risk, NVNO or PSTV?

Does the media favor NVNO or PSTV?

Do analysts recommend NVNO or PSTV?

Which has better valuation & earnings, NVNO or PSTV?

Do insiders and institutionals hold more shares of NVNO or PSTV?

Is NVNO or PSTV more profitable?

Summary

How does enVVeno Medical compare to PetVivo?

Is NVNO or PETV more profitable?

Do analysts recommend NVNO or PETV?

Which has more risk & volatility, NVNO or PETV?

Does the media refer more to NVNO or PETV?

Do institutionals & insiders have more ownership in NVNO or PETV?

Which has stronger earnings and valuation, NVNO or PETV?

Summary

How does enVVeno Medical compare to Cytosorbents?

Which has higher valuation & earnings, NVNO or CTSO?

Does the media prefer NVNO or CTSO?

Do analysts rate NVNO or CTSO?

Which has more risk & volatility, NVNO or CTSO?

Is NVNO or CTSO more profitable?

Do institutionals and insiders hold more shares of NVNO or CTSO?

Summary

How does enVVeno Medical compare to Retractable Technologies?

Which has better valuation and earnings, RVP or NVNO?

Does the media favor RVP or NVNO?

Do institutionals & insiders have more ownership in RVP or NVNO?

Which has more risk & volatility, RVP or NVNO?

Do analysts prefer RVP or NVNO?

Is RVP or NVNO more profitable?

Summary

How does enVVeno Medical compare to Lifeward?

Is LFWD or NVNO more profitable?

Do institutionals & insiders hold more shares of LFWD or NVNO?

Which has higher earnings & valuation, LFWD or NVNO?

Does the media favor LFWD or NVNO?

Do analysts prefer LFWD or NVNO?

Which has more volatility and risk, LFWD or NVNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools